Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;54(2):215-228.
doi: 10.1007/s00726-021-03108-2. Epub 2021 Dec 2.

In silico and in vivo neuropharmacological evaluation of two γ-amino acid isomers derived from 2,3-disubstituted benzofurans, as ligands of GluN1-GluN2A NMDA receptor

Arturo Coaviche-Yoval  1   2 , José G Trujillo-Ferrara  3 , Marvin A Soriano-Ursúa  3 , Erik Andrade-Jorge  3   4 , Luis A Sánchez-Labastida  3 , Héctor Luna  5 , Ricardo Tovar-Miranda  6
Affiliations

In silico and in vivo neuropharmacological evaluation of two γ-amino acid isomers derived from 2,3-disubstituted benzofurans, as ligands of GluN1-GluN2A NMDA receptor

Arturo Coaviche-Yoval et al. Amino Acids. 2022 Feb.

Abstract

The GABAergic and glutamatergic neurotransmission systems are involved in seizures and other disorders of the central nervous system (CNS). Benzofuran derivatives often serve as the core in drugs used to treat such neurological disorders. The aim of this study was to synthesize new γ-amino acids structurally related to GABA and derived from 2,3-disubstituted benzofurans, analyze in silico their potential toxicity, ADME properties, and affinity for the GluN1-GluN2A NMDA receptor, and evaluate their potential activity and neuronal mechanisms in a murine model of pentylenetetrazol (PTZ)- and 4-aminopyridine (4-AP)-induced seizures. The in silico analysis evidenced a low risk of toxicity for the test compounds as well as the probability that they can cross the blood-brain barrier (BBB) to reach their targets in the CNS. According to docking simulations, these compounds bind at the active site of the NMDA glutamate receptor with high affinity. The in vivo assays demonstrated that 4 protects against 4-AP-induced seizure episodes, suggesting negative allosteric modulation (NAMs) at the glutamatergic NMDA receptor. Contrarily, 3 (the regioisomer of 4) and its racemic derivatives (cis-2,3-dihydrobenzofurans) were previously described to exacerbate such episodes, pointing to their positive allosteric modulation (PAMs) of the same receptor.

Keywords: 2,3-Disubstituted benzofurans; 4-Aminopyridine (4-AP); NMDA receptor; Pentylenetetrazol (PTZ).

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Akyuz E, Paudel YN, Polat AK et al (2021) Enlightening the neuroprotective effect of quercetin in epilepsy: from mechanism to therapeutic opportunities. Epilepsy Behav 115:107701–107709. https://doi.org/10.1016/j.yebeh.2020.107701 - DOI - PubMed
    1. Alexander SP, Peters JA, Kelly E et al (2017) The concise guide to pharmacology 2017/18: ligand-gated ion channels. Br J Pharmacol 174:S130–S159. https://doi.org/10.1111/bph.13879 - DOI - PubMed - PMC
    1. Baragona F, Lomberget T, Duchamp C et al (2011) Synthesis of 5-substituted 2,3-dihydrobenzofurans in a one-pot oxidation/cyclization reaction. Tetrahedron 67:8731–8739. https://doi.org/10.1016/j.tet.2011.09.020 - DOI
    1. Bergmann R, Kongsbak K, Sørensen PL et al (2013) A unified model of the GABAA receptor comprising agonist and benzodiazepine binding sites. PLoS One 8:e52323. https://doi.org/10.1371/journal.pone.0052323 - DOI - PubMed - PMC
    1. Bhagat K, Singh JV, Pagare PP et al (2020) Rational approaches for the design of various GABA modulators and their clinical progression. Mol Divers. https://doi.org/10.1007/s11030-020-10068-4 - DOI - PubMed - PMC

LinkOut - more resources